SB 533

  • Oregon Senate Bill
  • 2025 Regular Session
  • Introduced in Senate Jan 13, 2025
  • Senate
  • House
  • Governor

Relating to restrictions on 340B covered entities.

Abstract

Creates a civil penalty for drug manufacturers that interfere directly or indirectly with certain entities acquiring 340B drugs, delivering 340B drugs to certain health care providers or dispensing 340B drugs. Creates a civil penalty for drug manufactures that require certain entities to submit utilization review data as a condition of acquiring, delivering or dispensing 340B drugs.

Bill Sponsors (3)

Votes


Actions


Apr 03, 2025

Senate

Work Session held.

Mar 06, 2025

Senate

Public Hearing held.

Jan 17, 2025

Senate

Referred to Health Care.

Jan 13, 2025

Senate

Introduction and first reading. Referred to President's desk.

Bill Text

Bill Text Versions Format
Introduced PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Oregon Legislative Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.